2024-12-24 08:57:57
HanAll Biopharma Assigns Su-jin Park as Co-CEO to Drive Next Phase of Growth
Corporate/ 2023-07-24
HanAll Biopharma Assigns Su-jin Park as ...

Su-jin Park joins HanAll Biopharma in a shared leadership role to strengthen pharmaceutical business in Korea,supporting growth in domestic ...

Transcenta's Osemitamab (TST001) Targeting Claudin18.2 Granted Orphan Drug Designation for Treatment of Pancreatic Cancer
Corporate/ 2023-07-24
Transcenta's Osemitamab (TST001) Ta...

SUZHOU,China,March 29,2023-- Transcenta Holding Limited ("Transcenta") (HKEX: 06628),a clinical stage biopharmaceutical company wi...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release